Your browser doesn't support javascript.
loading
The advisory process for anticancer drug regulation: a global perspective.
Farrell, A T; Papadouli, I; Hori, A; Harczy, M; Harrison, B; Asakura, W; Marty, M; Dagher, R; Pazdur, R.
Affiliation
  • Farrell AT; United States Food and Drug Administration, Center for Drug Evaluation and Research Office of New Drugs, Office of Oncology Drug Products, Division of Drug Oncology Products, Silver Spring, MD 20993, USA. farrella@cder.fda.gov
Ann Oncol ; 17(6): 889-96, 2006 Jun.
Article in En | MEDLINE | ID: mdl-16357020
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Legislation, Drug / Antineoplastic Agents Type of study: Guideline Limits: Humans Country/Region as subject: America do norte / Asia / Oceania Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Legislation, Drug / Antineoplastic Agents Type of study: Guideline Limits: Humans Country/Region as subject: America do norte / Asia / Oceania Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido